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The discovery of microRNAs (miRNAs) as a new class of regulators of gene 
expression has triggered an explosion of research, but has left many unanswered 
questions about how this regulation works and how it is integrated with other 
regulatory mechanisms.  A number of miRNAs have been found to be present in 
blood plasma and other body fluids of humans and mice in surprisingly high 
concentrations.   This observation was unexpected in two respects: first, the fact 
that these molecules are present at all outside the cell at significant 
concentrations; and second, that these molecules appear to be stable outside of 
the cell.  In light of this it has been suggested that the biological function of 
miRNAs may also extend outside of the cell and mediate cell-cell communication 
[1-5]. Such a system would be expected to export specific miRNAs from cells in 
response to specific biological stimuli.  We report here that after serum 
deprivation several human cell lines tested do export a spectrum of miRNAs into 
the culture medium. The export response is substantial and prompt.  The 
exported miRNAs are found both within and outside of microvesicles and 
exosomes. We have identified some candidate protein components of this system 
outside the cell, and found one exported protein that plays a role in protecting 
miRNA from degradation. Our results point to a hitherto unrecognized and 
uncharacterized miRNA trafficking system in mammalian cells that may involve 
cell-cell communication. [234 words] 
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One of the hypotheses advanced to explain the biological significance of the presence of 
miRNA in the plasma is that they are part of a cell-cell communication system. This 
biological function would require that the miRNAs convey specific information, and 
therefore that only certain miRNAs are exported from cells in response to biological 
stimuli.  This export mechanism would have to be able to select specific miRNAs for 
export in response to the specific cellular state of the exporting cell, and transport these to 
the extra-cellular space in a form suitable to be taken up by another cell.  To our 
knowledge no such mechanism has yet been described or even hypothesized.   
 
For cells in culture, we report here observations that indicate the existence of such a 
system.  Specifically, we asked whether there is a significant difference between the 
miRNA spectrum within growing cells and the spectrum of miRNAs found in the 
external medium.   We examined this question using miRNA array profiling for several 
different cell lines.  The results, shown in figure 1a, are that the several different cell 
types examined all exhibited striking differences between internal and external 
spectra(groups marked as “out” or “in” on the figure for HepG2).  While there could be 
several possible explanations for this, including preferential stability inside or outside the 
cell, these results are consistent with the specific export hypothesis.  We carefully looked 
for evidence of cell lysis in all these cultures (by measuring the levels of LDH in the 
medium at several time points, and examining the cells and culture media 
microscopically). The LDH levels in serum free media showed no significant changes 
during the experimental period, up to 48 hours of serum depletion (data not shown.)    
Finding no detectable evidence of lysis we concluded that the external miRNAs are 
exported from intact cells, consistent with the observed striking difference between 
intracellular and extracellular miRNA spectra (see below.)   
 
A strong biological stimulus to cells growing in culture is caused by depriving them of 
the various factors present in culture medium supplemented with serum. Cells must alter 
their internal states significantly when so stimulated, including cell cycle arrest and in 
some cases cell death during extended periods of serum depletion [6].    Thus, a testable 
hypothesis is that when deprived of serum cells respond to their change of state in part by 
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exporting miRNAs.   To test this, we carefully characterized the miRNA spectra of two 
different cell lines long established in culture, A549 and HepG2, which were derived 
from different sources. HepG2 is derived from a human hepatocellular carcinoma, and 
A549 from lung epithelial carcinoma.  The absence of miRNAs present in bovine serum 
is a distinct advantage of using serum depletion to study extracellular miRNA as it 
removes a potential source of interference. When these cells are stimulated by serum 
deprivation, several notable changes of miRNA levels occur.  Validation and cross-
checking of the array results, shown in figure 1a, was performed for HepG2 and A549 by 
Q-PCR on selected miRNAs, as indicated in figure 1b and c.  There are 499 and 578 
observable miRNA species in A549 cells and HepG2 cells, respectively.  Among these 
there are 476 miRNAs in common between the two cell lines.  Fewer than 5% of the 
miRNAs observed in A549 cells are not observed in HepG2, and fewer than 18% of the 
miRNAs observed in HepG2 are not observed in A549.  In the culture media, the 
percentages are similar (2% of the miRNAs observed from A549 are not observed from 
HepG2, and 15% of the miRNAs observed from HepG2 are not observed from A549).  
Based on the global miRNA profiling results, we selected a set of 30 miRNAs that 
showed good signals and consistent measurement profiles with Q-PCR  to study in more 
detail.    
 
In order to track the cellular responses carefully we carried out a time series of 
measurements from just before serum deprivation (SD) to 48 hours after SD.   This 
revealed some dramatic differences in the profile of external miRNAs in time, not only 
among specific species, but also some differences between cell lines.  If we compare the 
changes in levels of certain miRNAs inside and outside the cells, before and after serum 
deprivation, the rate of export for most of the miRNAs examined increases dramatically 
during the first 2 hours after SD and declines thereafter (figure 2.)     
 
One observation from these data was that some miRNAs exhibited a modest decline in 
concentration in the medium after increasing strongly in the first few hours (e.g. miR-
135a, 133b).  To determine whether these miRNAs were specifically being degraded in 
the serum-free culture medium, we carried out extensive time point measurements of the 
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decay of miRNA in media from which the cells were removed.    The data clearly show 
(figure 4c, d) that different miRNAs decay at different rates.  As shown in Figure 3 and in 
the supplementary material (S1), the decay of miRNAs in the medium over many hours is 
readily detectable, but not severe for most miRNA species. The overall decay rate doesn’t 
appear to be greater than 0.02/hr (this decay constant is defined in Figure 3 as the 
coefficient in the exponent of 2) in any single case.   
  
The time series data, taken together with the miRNA decay measurements, enables us to 
estimate the quantitative kinetics of the export of miRNA from cells after SD.   Since the 
levels rise rapidly in the first 2 hours or so after SD and then remain roughly constant or 
decay somewhat, we conclude that for these miRNAs there is a strong pulse of exported 
miRNA that rapidly subsides, accompanied by the steady, but relatively slow, decay of 
the miRNA outside the cell.  Modeling of simple kinetics of this kind shows that most of 
our data is consistent with the general scheme of kinetics illustrated in Figure 3c.  This 
kinetic profile, with a rapid rise in export rate, raises the question of whether or not the 
miRNA exported is pre-synthesized and prepackaged.   
 
We measured the intracellular levels as well as the exported miRNA levels in the medium 
after SD for a large set of miRNAs from both cell lines.  We illustrate our general 
observations in figure 3d: an initial intracellular drop in miRNA levels simultaneous with 
a strong increase in external levels.  The Q-PCR data shown here for 3 representative 
miRNAs also indicates a recovery of intracellular levels after a few hours (2-6 hrs).   In 
order to see the overall behavior of intracellular miRNA dynamics, we averaged all 24 of 
the exported miRNA that were measured at each time point.  These 24 miRNAs (those 
that exhibited standard deviation of the 3 replicates of less than 1.4) provide us with 
strong qualitative view of the dynamics. The corresponding average dynamics of 
exported miRNA concentration in the medium during a period of 30 hours after SD are 
shown in figure 3e.  An expanded view of the behavior of these miRNA averaged 
miRNA dynamical levels during the first 2 hours after SD, inside and outside the cell, 
shown in figure 3f, illustrates the precise behavior expected from the kinetic model we 
propose.  In addition, it seems that the levels of intracellular miRNA overshoot then tend 
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to relax back to their original levels. They are notably closer to the pre-SD levels after 24 
hours (Figure 3e).   The relatively short export response time and this analysis strongly 
suggest that most of the exported miRNAs are initially from a pre-synthesized pool since 
the substantial export in the first hour is unlikely to come from newly transcribed and 
processed miRNA.  The initial reduction in intracellular levels is consistent with this 
view.  This hypothesis will be carefully investigated in the future.   
 
Up to now, observations of miRNA outside cells have been focused on known cell-
derived vesicles, like micro-vesicles and exosomes [1,2].   In the serum deprivation 
system used here, we were able to examine the question of how the exported miRNA are 
contained or packaged in more detail.   We fractionated the medium containing the 
exported miRNAs and determined the miRNA content of each fraction.  The absence of 
interfering bovine miRNAs, proteins, and other bovine serum derived biological products 
in the serum-free medium enables quantitative measurements that are more accurate and 
reproducible than possible otherwise. Using well-developed differential centrifugation 
based methods for micro-vesicle and exosome isolation [7], we fractionated the media 
isolated from the cultures 2 hours after SD, into 4 fractions (Figure 4a).  The microvesicle, 
exosome, “hard spin” pellet (the latter is the pellet of a final 220K x g spin for 1 hr), and 
supernatant fractions were then assayed for the presence of the miRNA species examined 
in the previous figures.  The results of these measurements (3 biological replicates – 
repeated experiments) are presented in figure 4(b-d) and were surprising in several 
respects.  First, counter to the expectation that miRNA is confined to previously 
described cell-derived vesicles; all of the miRNAs are found at significant concentrations 
in the final supernatant fraction in serum depletion conditions.  The second surprise is 
that many, but not all, of the miRNAs are also found both in the vesicles and the 
supernatant.  The patterns of distribution showed a strong diversity of profiles, falling 
into 3 to 5 distinct patterns (Figure 4b-h).   
 
The most extreme differences are shown in figure 4 panels b - e, where we illustrate the 
distributions of several miRNA species.  Note that there are several miRNAs that are 
found in almost equal proportions in all four fractions, while several that are almost 
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completely absent from all but the supernatant fraction.   This result strongly counters the 
idea that the presence of miRNA in the final supernatant is due to disruption of cell 
derived vesicles during fractionation procedures.  The data also suggest that many of the 
vesicles remain intact (as evidenced by the high levels of some miRNA seen in this 
fraction). Therefore, the absence of some of the miRNAs, present in the supernatant, in 
the vesicle fraction cannot be explained by ruptured vesicles.   Thus, while the 
measurements from all these fractions demonstrate some experimental noise, it is clear 
that the dramatic quantitative differences represent real qualitative differences between 
miRNA distributions.  These observations of miRNA distribution demonstrate that the 
miRNA export system in the cells must somehow target specific miRNA to specific 
extracellular structures, but does not exclusively channel specific miRNAs to a given 
fraction.  There are, however, some miRNAs that are found in the supernatant almost to 
the exclusion of all other fractions (miR-219 in figure 4b, for example).  Another 
significant observation from this data is that even though we showed that the two cell 
lines studied here export a similar spectrum of miRNAs (figure 1b) the distributions of 
miRNAs from the two cell lines demonstrate clear differences, as shown in figure 4 b-h. 
For example, miR-145 is present at very low levels in HepG2 derived microvesicles 
(Figure 4d), while when this same miRNA is exported from A549 it is present at  
significant levels in both microvesicles and exosomes (Figure 4c).   On the other hand, 
there are some miRNAs, notably those that are almost uniformly distributed among the 
fractions, with the same distribution no matter which cell-line is the source.   These 
observations certainly indicate the degree of complexity of this export system that will 
bear further investigation.  
 
To further investigate the miRNA exporting process, we treated the HepG2 cells with 
different concentration of rotenone, a respiratory chain inhibitor to reduce the cellular 
ATP level, and brefeldin A (BFA), an inhibitor of protein secretion through the 
interference with the Golgi apparatus, for 30 minutes prior to SD.  As expected, the 
cellular ATP level showed a significant decrease in rotenone treated cells while the LDH 
levels in media showed no significant changes in either treatment.  We then examined 
levels of selected miRNAs with Q PCR in both cells and culture media.  The level of 
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miRNAs inside the cells showed no significant changes in either treatment; however, the 
levels of most of the extracellular miRNAs examined displayed a dose dependent 
decrease with rotenone treatment only (see data in supplementary material).  This finding 
suggests that:  1) most of the miRNA exporting process is probably energy dependent – 
an active transport process, and 2) during the time frame examined, the exporting process 
is not affected by BFA – a process independent of the Golgi apparatus. It is interesting to 
note that the extracellular levels of three miRNAs we measured, mir-671-3P, mir-943 and 
mir-302c are not affected by the decrease of cellular ATP level, suggesting that the 
export pathway is more complex and involves multiple branches.   
 
To examine the protein content of the exported complexes, we collected and concentrated 
the primary human fibroblast medium 2 hours after SD, digested the protein contents 
with trypsin and examined the peptides by mass spectrometry.  We then identified all the 
proteins that were represented by more than one peptide – an unexpectedly large total of 
197 proteins.  Of these, 12 were known RNA-binding proteins (Table 1). Besides several 
ribosomal proteins, it is notable that there was a substantial level of a known nucleolar, 
RNA binding protein, nucleophosmin (NPM1), in the medium.  Nucleophosmin is 
implicated in the nuclear export of the ribosome [7].  There was also a significant amount 
of nucleolin, a known NPM1 interacting protein, in the medium.  Since NPM1 is known 
to be located primarily in the nucleolus and involved ribosomal RNA processing, it is 
surprising to observe it in significant levels outside the cell.   Using an antibody to 
nucleophosmin, we identified the NPM1 protein in culture media from other cell lines as 
well as HepG2 at 2 hours after SD.  We also examined NPM1 protein levels in different 
fractions of culture medium.  The vast majority of the protein is present only in the 
supernatant fraction (as defined in figure 4a), and is undetectable by Western blot in 
either vesicle fraction.   Thus, the distribution of NPM1 protein in different fractions of 
HepG2 medium, illustrated in figure 5a, parallels the distribution of miRNAs – by far the 
largest concentration is found in the supernatant (figure 5b). The presence of a RNA-
binding protein in this fraction, where most of the miRNAs are found, suggests miRNAs 
may be bound by this protein. We carried out a number of experiments, including gel 
shifts and immunoprecipitations (data not shown), that confirm the binding of 
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nucleophosmin to miRNAs. To see whether NPM1 might be responsible for the stability 
of the external miRNA, we incubated synthetic miR-122 with purified NPM1 protein and 
challenged the mixture with RNaseA.  We found that NPM1 alone can fully protect this 
miRNA from digestion (figure 5c.).  It has been suggested that NPM-1 may be involved 
in shuttling RNAs and ribosomal proteins to the cytosol [8], and, in a recent report, that it 
can be found outside the cell [9].   This shuttling mechanism may be relevant to a 
possible role in miRNA export. In knockdown experiments, using siRNA against NPM1 
message, we reduced the of this protein in the cells and saw corresponding reductions in 
miRNA export (data not shown.) Our findings collectively are highly suggestive that the 
miRNA-associated protein nucleophosmin is involved both in some part of the miRNA 
exporting process and in protecting the external miRNAs outside the cell.  
 
We have demonstrated that miRNAs are actively exported from cells after serum 
deprivation.  They appear to be exported in a pulse lasting about one hour after serum 
deprivation.  This export system has not been reported before, to our knowledge, and 
strongly suggests both the existence of a complex response system and the possible 
involvement of miRNA in cell-cell communication.    Our results also suggest that 
previous reports of extracellular vesicle-associated miRNAs represent only a part of the 
extracellular miRNA distribution, at least in our cell culture conditions. A significant 
fraction of extracellular miRNA is, in fact, not within the known cell-derived vesicles.  It 
is yet unclear how they are packaged outside these vesicles.   This leads us to  speculate 
that there may be at least two pathways for the packaging and export of miRNAs – 
exosome/microvesicle mediated and “other particle” mediated processes. We were 
surprised to find a number of reportedly intracellular proteins in the culture media shortly 
after serum depletion.  At least one of these associated RNA binding proteins, NPM1, 
may play a role in the packaging, and perhaps the export, of extracellular miRNAs.  Its 
role in miRNA packaging/exporting is currently being investigated. 
 
The hypothesis of miRNA-dependent cell-cell communication based on the export of 
miRNA seems to be the most satisfying explanation for the cellular export phenomena of 
miRNA.   There has been circumstantial evidence in favor of this interpretation, but we 
 miRNA export from mammalian cells                                                                                  8/29/09  
 
 9
provide here direct evidence that: demonstrates the export system in action, characterizes 
some of its properties, and supports the miRNA mediated cell-cell communication idea.  
Our biological observations indicate an important role of miRNAs, and enable future 
investigations of this potential communication system, unknown until now.   
 
There are important pieces of the puzzle still missing. We have no direct evidence yet 
that miRNA complexes are taken up by other cells, although vesicles containing miRNA 
are reported to be taken up by cells.  We expect that miRNA outside of vesicles, 
complexed with proteins, could be targeted to specific cell surface receptors, and are 
currently investigating this important hypothesis.   Our results raise significant questions 
about miRNA mediated cell-to-cell communication, and enable the characterization of 
such a system.  The elucidation of a novel, and perhaps extensive, biological information 
transduction system between cells will certainly be of the utmost importance in  
understanding many biological processes in mammalian systems including development, 
stress response and tissue renewal.   
 
Methods 
Cell culture  
The HepG2, A549, T98 and BSEA2B cells were obtained from The American Type 
Culture Collection (ATCC, Manassas, VA) and grown in recommended medium 
containing 10% fetal bovine serum (FBS), 100U/ml penicillin and 100 µg/ml 
streptomycin (Invitrogen, Carlsbad, CA) at 37 °C under 5% CO2.  We determined that 
this strain of HepG2 does not express CYP2E1. The primary human pulmonary fibrobast 
cells were obtained from Sciencell Research Laboratories (Sciencell, Carlsbad, CA) and 
grown in Fibroblast medium (Sciencell, Carlsbad, CA) on collagen I coated cell culture 
flasks (Becton Dickinson, Franklin Lakes, NJ).  For serum depletion experiments, the 
cells were inoculated and grown for 24 hours with 10% FBS containing media prior to 
switching to serum-free media.  Serum free medium contained the basic medium as 
provided by Invitrogen (Carlsbad, CA) with 100U/ml penicillin and 100µg/ml 
streptomycin.  For rotenone and brefeldin A treatments, the cell were inoculated and 
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grown for 24 hours with 10% FBS prior to exposing the cells with different concentration 
of drugs for 30 minutes.  Lactate dehydrogenase (LDH) levels were determined with 
LDH-Cytotoxicity assay kit from Abcam (Abcam Inc., Cambridge, MA) and ATP levels 
were determined with ENLITEN ATP assay system (Promega, Madison, WI). 
RNA extraction 
Total RNA including miRNA was isolated using miRNeasy kit (Qiagen, Germantown, 
MD) with minor modifications that have been previously described [3]. In summary, 
700ul of QIAzol reagent was added to 300ul of culture medium samples, followed by 
adding 140 ul of chloroform. The samples were mixed vigorously for 15 seconds and 
centrifuged at 12,000x g for 15 minutes at 4°C to separate the aqueous and organic layers. 
After transferring the aqueous phase to a new collection tube, 1.5 volumes of ethanol 
were added and the samples were then applied to RNeasy mini column. Total RNA was 
eluted from the membrane with 30 ul of RNase-free water.   
Quantitative RT-PCR 
The cDNA was generated using the miScript Reverse Transcription kit (Qiagen, 
Germantown, MD). In brief, miRNAs were polyadenylated by using poly(A) polymerase 
and cDNA was generated with reverse transcriptase using a tag containing oligo-dT 
primers. The tag on oligo-dT served as universal primer in QPCR step. 
Human miScript Assay 384 set v10.1 (Qiagen, Germantown, MD) was used for real-time 
PCR analysis. To reduce pipetting error, the Matrix Hydra eDrop (Thermo Scientific, 
Hudson, NH) was used to mix the cDNA sample and qPCR master reagent.  The data was 
analyzed by SDS Enterprise Database 2.3(Applied Biosystems, Foster City, CA).  
Microarrays 
miRNA microarrays were performed using the manufacturer’s (Agilent, Santa Clara, CA) 
protocol as previously described [ 3] . 100ng of total RNA was dephosphorylated with 
calf intestinal alkaline phosphate, and denatured with heat in the presence of dimethyl 
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sulfoxide (DMSO). T4 RNA ligase added the Cyanine 3-cytidine biphosphate (pCp) to 
the dephosphorylated single stranded RNA. MicroBioSpin 6 columns (Bio-Rad, Hercules, 
CA) were used to remove any unincorporated cyanine dye from the samples. The purified 
labeled miRNA probes were hybridized to human miRNA V2 oligo microarrays in a 
rotating hybridization oven at 10 rpm for 20h at 55 C. After hybridization, the arrays 
were washed in Agilent GE Wash Buffer 1 and 2 with Triton X-102. Then the array 
slides were dried immediately by a nitrogen stream and scanned at 5-um resolution by 
using a PerkinElmer ScanArray Express array scanner.  
 
Fractionation of culture medium 
 
The cells were grown as stated above. The serum free media were collected and 
centrifuged at 1000 x g for 10 minutes to remove cell debris.  This supernatant (25 ml) 
was transferred to a new tube and spun at 16K x g for 60 minutes, the pellet 
microvesicles, were washed and resuspended in phosphate-buffered saline (PBS, 137 mM 
NaCl, 2.7 mM KCl, 10 mM Sodium Phosphate dibasic, 2 mM Potassium Phosphate 
monobasic at pH of 7.4). The supernant of the 16K x g spun was transferred to a new 
tube and further centrifuged at 120K x g for 60 minutes to pellet the exosome particles.  
The exosome depleted supernatant was then spun at 220K x g for 60 minutes. The final 
supernatant was concentrated using Amicon Ultra Centrifugal Filter Devices (Millipore, 
Billerico, MA) to a final volume of 0.5ml.  The pellets, microvesicles, exosomes, and 
220K x g pellet were resuspended in 0.5ml PBS, so that the total volume of medium 
contributing to each was identical.  
 
 
Mass Spectrometry Sample Preparation and Data Analysis 
 
Cells were grown as above and the serum free media was concentrated using Amicon 
Ultra Centrifugal Filter Devices (Millipore, Billerico, MA). The concentrated media was 
enzymatically digested with trypsin and desalted with C18 Ultramicrospin columns (The 
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Nest Group, Southborough, MA). After drying in a Savant speedvac (Thermo Scientific, 
Waltham, MA) the sample was re-suspended and run on Q-TOF Ultima API Mass 
Spectrometer (Waters, Bedford, MA). The results were analyzed using SEQUEST (v.27) 
against a human International Protein Index (IPI) database (v.3.38).  
 
Western blots  
 
Concentrated medium and pellet samples were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were transferred to a 
nitrocellulose membrane (Bio-Rad, Hercules, CA). Human NPM1 was detected on the 
western blot blocked with 5% nonfat dry milk using an anti-NPM1 monoclonal antibody 
(Sigma, St. Louis, MO). Near-infrared (NIR) IRDye 680 labeled secondary antibodies 
(Li-Cor, Lincoln, NE) were used to visualize the NPM1 antibody. The membrane was 
scanned using the Odyssey infrared imaging system (Li-Cor, Lincoln, NE).  
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Figure legends 
 
Figure 1. Differential miRNA spectra between cultured cells and the medium.  a.  Intra 
and extra-cellular miRNA spectra for 6 different cell lines in culture as measured by 
miRNA arrays.  The cell lines are as indicated (T98 is derived from human glioblastoma 
multiforma, BEAS2B is  derived from lung bronchial epithelium, and HPF are  primary 
pulmonary fibroblast cells isolated from human lung tissue).  Heat maps represent the 
levels of miRNA for the cell lines as indicated (red highest, green lowest).  The brackets 
indicating “in” or “out” mark groups of miRNAs that show striking differences between 
the intra (“in”) and extra (“out”) cellular concentrations specifically for HepG2 cells.  b. 
Q-PCR measurements of selected miRNAs shown in 1a that illustrate different profiles  
for HepG2 (red)  and A549 (blue).   The histogram shows the external versus internal 
levels of selected miRNAs, in a log2 scale.  The extra-cellular levels are indicated above, 
the intra-cellular below.  c. Extra-cellular levels of miRNAs expressed from A549 and  
HepG2 cells .   The upper frame represents the relative levels (expressed in terms of  
log2), while the lower frame represents the standard deviations of these measurements in 
the upper frame (3 biological replicates) also in terms of log2. 
 
Figure 2.  Time course of levels of miRNA exported  into the medium. Samples were 
taken  at various indicated time points taken serum deprivation.  The serum free medium 
contains no proteins or miRNAs.  Most of the miRNA measured shown very similar 
behavior.  All vertical axes are in log2.  a.   The levels for 16 miRNAs measured by 
quantitative PCR from A549 (left frame and HepG2 (right frame). The points are the 
means of 3 biological replicates each.   b.   The time course measurements for three 
selected miRNAs from these same cell lines (same frame positions)  that show the 
standard deviations for the replicates.   
 
Figure 3.   Decay of miRNAs in the medium.  The cells in culture were serum deprived 
for 2 hours, then the medium was removed and incubated under the same conditions for 
varying periods of time.  miRNA measurements were made (3 biological replicates) by 
specific quantitative PCR on each sample. a. The time course measurements of 4 selected 
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miRNAs showing diverse profiles, and their standard deviations.  b.  Fitting the decay 
curves by least squares gives  an effective decay constant, plotted here for the 4 miRNAs 
in c.   c.  Model kinetics for the export response of the majority of the miRNAs 
considered here, showing the rate of export as a function of time (in red) and the 
accumulated level as a function of time (in blue).   d. the intracellular response in HepG2 
cells of three selected miRNAs. g. the extracellular levels from the same experiment 
( three biological replicates) of the same three miRNAs.  e.  a “score card” showing  
which  miRNA showed definitive evidence of decreasing in the cell immediately after SD 
(marked with a cross indicating that the average of values at 0.5 and 1 hr after SD show a 
decrease)  together with  a profile of intra and extracellular levels averaged over the set of 
all 24 miRNA measured (3 biological replicates of each.).  f.  An expanded view of the 
averaged profile shown in e.  The 0 hr point shown is that of the miRNA prior to the 
serum deprivation, even though the serum free medium begins at  0 hr with no miRNAs 
present.  
  
Figure 4.  miRNA levels in fractionated serum-free culture medium for the two cell lines.  
The medium was fractionated (2 hours  after serum deprivation) by differential 
centrifugation into four fractions using standard protocols for isolating microvesicles 
(size range: 100nm to 1000nm), exosomes (size range: 30nm to 100nm)  ,  one higher g 
spin pellet (220K for 1 hour), and the remaining supernatant.  Pellets were resuspended in 
0.5 ml of PBS and 200 ul of the solution were used for miRNA isolation.      a.  
Experimental design for fractionation of medium.  Panels b through e show 2 selected 
sets of 3 miRNAs profiles from the two cell lines compared. The bars show the standard 
deviations of 3 biological replicates. 
 
Figure 5.   Protein exported upon serum deprivation. a.  NPM1 protein is observed in 
Western analysis of the concentrated medium from HepG2 cells.  This protein is exported 
into the medium, but is not found in any fraction except the supernatant (as defined in 
legend to figure 4 ) as shown by Westerns on the fractions.   b. The relative 
concentrations of all miRNAs measured in this work were averaged for each fraction to 
obtain a relative measure of miRNA levels in each fraction. These averages for HepG2 
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cells are are shown in the histogram using a scale of log to base 2.   c.   NPM1 protein 
protects microRNA from RNase degradation.  Synthetic mir-122 (100pmole) was mixed 
with different proteins, NPM1 (blue bars, 3 pmole), TGF-β (purple bars, 4 pmole) or 
BSA (yellow bars, 1.5 nmole) for 30 minutes followed by adding RNase A (7 nmole) for 
another 30 minutes and incubation at 37oC.  The miRNA levels were determined by Q-
PCR.  Control experiments: omitting RNAse A, protein, or microRNA were also 
included, as indicated on top of the graph.  The scale is log2 of  relative mir-122 levels. 
 
Table I.     We show here all of the known  RNA binding proteins for which we observed 
2 or more peptide fragments in the medium (2hrs after SD)  .   
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Figure 1 c  
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Table I 
Gene Symbol
Number of 
peptides 
observed
Gene Name
HNRNPA2B1 2 heterogeneous nuclear ribonucleoprotein a2/b1
HNRPAB 3 heterogeneous nuclear ribonucleoprotein a/b
ILF2 2 interleukin enhancer binding factor 2, 45kda
NCL 7 nucleolin
NPM1 4 nucleophosmin (nucleolar phosphoprotein b23, numatrin)
RPL10A 2 ribosomal protein l10a
RPL5 2 ribosomal protein l5
RPLP1 6 ribosomal protein, large, p1
RPS12 2 ribosomal protein s12
RPS19 2 ribosomal protein s19
SNRPG 2 small nuclear ribonucleoprotein polypeptide g
TROVE2 2 trove domain family, member 2
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